| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
586 |
569 |
$138K |
| 71046 |
Radiologic examination, chest; 2 views |
876 |
846 |
$125K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
342 |
293 |
$93K |
| 80053 |
Comprehensive metabolic panel |
691 |
626 |
$74K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,677 |
1,513 |
$67K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,356 |
834 |
$66K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
413 |
409 |
$58K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,222 |
1,155 |
$58K |
| 59025 |
Fetal non-stress test |
194 |
152 |
$54K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
165 |
134 |
$53K |
| 87070 |
|
926 |
880 |
$46K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
846 |
649 |
$45K |
| 84443 |
Thyroid stimulating hormone (TSH) |
360 |
344 |
$38K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
430 |
406 |
$36K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
429 |
406 |
$36K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
106 |
105 |
$35K |
| 73630 |
|
214 |
202 |
$33K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
450 |
419 |
$28K |
| 73610 |
|
149 |
145 |
$23K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
60 |
57 |
$15K |
| 76830 |
Ultrasound, transvaginal |
52 |
52 |
$15K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
143 |
141 |
$14K |
| 80061 |
Lipid panel |
152 |
149 |
$13K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
106 |
104 |
$13K |
| 76801 |
|
42 |
39 |
$12K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
68 |
65 |
$12K |
| 73130 |
|
76 |
71 |
$11K |
| 87186 |
|
188 |
173 |
$10K |
| 81001 |
|
263 |
256 |
$8K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
173 |
58 |
$8K |
| 86900 |
|
81 |
80 |
$8K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
63 |
59 |
$8K |
| 80076 |
|
104 |
100 |
$7K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
45 |
41 |
$6K |
| 86850 |
|
67 |
67 |
$6K |
| 87660 |
|
83 |
79 |
$5K |
| 87510 |
|
83 |
79 |
$5K |
| 87480 |
|
83 |
79 |
$5K |
| 88142 |
|
78 |
78 |
$5K |
| 86901 |
|
81 |
80 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
59 |
56 |
$4K |
| 87184 |
|
114 |
108 |
$4K |
| 76536 |
|
12 |
12 |
$3K |
| 73140 |
|
26 |
25 |
$3K |
| 73030 |
|
28 |
25 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
76 |
69 |
$3K |
| 84439 |
|
41 |
40 |
$3K |
| 86703 |
|
78 |
75 |
$2K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
12 |
12 |
$2K |
| 73110 |
|
14 |
14 |
$2K |
| 86803 |
|
28 |
28 |
$2K |
| 74019 |
|
12 |
12 |
$2K |
| 83690 |
|
106 |
100 |
$2K |
| 72110 |
|
12 |
12 |
$2K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
111 |
88 |
$1K |
| 85027 |
|
41 |
39 |
$1K |
| 85610 |
|
67 |
55 |
$1K |
| 86592 |
|
43 |
41 |
$1K |
| 86618 |
|
14 |
13 |
$1K |
| 87806 |
|
12 |
12 |
$1K |
| 87205 |
|
41 |
40 |
$968.83 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
13 |
13 |
$934.52 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
13 |
12 |
$878.27 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
16 |
16 |
$794.88 |
| 84484 |
|
56 |
42 |
$770.92 |
| 81003 |
|
40 |
40 |
$750.95 |
| 87081 |
|
16 |
16 |
$729.80 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
13 |
13 |
$619.08 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
18 |
18 |
$614.96 |
| 85007 |
|
27 |
25 |
$497.42 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
17 |
16 |
$147.83 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
13 |
13 |
$142.79 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
15 |
13 |
$28.98 |
| 71045 |
Radiologic examination, chest; single view |
13 |
12 |
$10.77 |
| 3008F |
|
12 |
12 |
$0.00 |